Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

The presence of lymph node metastases is a well-studied prognostic factor for cutaneous melanoma. Characterization of melanoma lymph node metastases and their association with survival in multiple, large observational studies has led to recognition of the following high-risk features: quantity of ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhodin, Kristen E., Fimbres, Denisse Porras, Burner, Danielle N., Hollander, Shayna, O’Connor, Margaret H., Beasley, Georgia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675405/
https://www.ncbi.nlm.nih.gov/pubmed/36411863
http://dx.doi.org/10.3389/fonc.2022.1021057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675405/
https://www.ncbi.nlm.nih.gov/pubmed/36411863
http://dx.doi.org/10.3389/fonc.2022.1021057

Ejemplares similares